文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

功能性消化不良中的重叠反流症状大多与胃食管反流无关。

Overlapping Reflux Symptoms in Functional Dyspepsia Are Mostly Unrelated to Gastroesophageal Reflux.

作者信息

Chen Songfeng, Jia Xingyu, Zhuang Qianjun, Hou Xun, Siah Kewin T H, Zhang Mengyu, Chen Fangfei, Tan Niandi, Hu Junnan, Xiao Yinglian

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangdong, China.

Gastrointestinal Surgery Center, The First Affiliated Hospital of Sun Yat-sen University, Guangdong, China.

出版信息

J Neurogastroenterol Motil. 2025 Apr 30;31(2):218-226. doi: 10.5056/jnm24091.


DOI:10.5056/jnm24091
PMID:40205898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11986649/
Abstract

BACKGROUND/AIMS: Reflux symptoms frequently present in patients diagnosed with functional dyspepsia (FD). This investigation sought to elucidate the contribution of gastroesophageal reflux in the overlap relationship. METHODS: Consecutive patients presenting with reflux symptoms and/or FD symptoms were prospectively included. Comprehensive assessments, including symptoms evaluation, endoscopy, esophageal functional examinations (high-resolution manometry and reflux monitoring), and proton pump inhibitor (PPI) treatment efficacy evaluation, were conducted in these patients. RESULTS: The study enrolled 315 patients, 43.2% of which had concurrent FD symptoms and overlapping reflux symptoms. Notably, a mere 28.7% of patients in the overlap symptoms group had objective gastroesophageal reflux disease evidences (the grade of esophagitis ≥ B or the acid exposure time ≥ 4.2%). Functional heartburn was demonstrated to be the main cause of overlapping reflux symptoms (55.1%). Reflux parameters analysis revealed that the reflux burden in the overlap symptoms group paralleled that of the FD symptoms group, with both registering lower levels than the reflux symptoms group ( < 0.05). Furthermore, PPI response rates were notably diminished in the overlap symptoms group ( < 0.001), even for those with objective gastroesophageal reflux disease evidences. CONCLUSIONS: The study illuminated that overlapping reflux symptoms in FD was common. Strikingly, these symptoms primarily diverged from reflux etiology and exhibited suboptimal responses to PPI intervention. These findings challenge prevailing paradigms and accentuate the imperative for nuanced therapeutic approaches tailored to the distinctive characteristics of overlapping reflux symptoms in the context of FD.

摘要

背景/目的:反流症状在诊断为功能性消化不良(FD)的患者中经常出现。本研究旨在阐明胃食管反流在重叠关系中的作用。 方法:前瞻性纳入出现反流症状和/或FD症状的连续患者。对这些患者进行了全面评估,包括症状评估、内镜检查、食管功能检查(高分辨率测压和反流监测)以及质子泵抑制剂(PPI)治疗疗效评估。 结果:该研究纳入了315例患者,其中43.2%同时有FD症状和重叠的反流症状。值得注意的是,重叠症状组中仅有28.7%的患者有客观的胃食管反流病证据(食管炎分级≥B级或酸暴露时间≥4.2%)。功能性烧心被证明是重叠反流症状的主要原因(55.1%)。反流参数分析显示,重叠症状组的反流负担与FD症状组相当,两者均低于反流症状组(<0.05)。此外,重叠症状组的PPI反应率显著降低(<0.001),即使是那些有客观胃食管反流病证据的患者。 结论:该研究表明FD中的重叠反流症状很常见。令人惊讶的是,这些症状主要与反流病因不同,并且对PPI干预的反应欠佳。这些发现挑战了主流范式,并强调了针对FD背景下重叠反流症状的独特特征制定细致治疗方法的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4741/11986649/c4b6ecac919a/jnm-31-2-218-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4741/11986649/51873351baff/jnm-31-2-218-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4741/11986649/c4b6ecac919a/jnm-31-2-218-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4741/11986649/51873351baff/jnm-31-2-218-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4741/11986649/c4b6ecac919a/jnm-31-2-218-f2.jpg

相似文献

[1]
Overlapping Reflux Symptoms in Functional Dyspepsia Are Mostly Unrelated to Gastroesophageal Reflux.

J Neurogastroenterol Motil. 2025-4-30

[2]
The Therapeutic and Diagnostic Value of 2-week High Dose Proton Pump Inhibitor Treatment in Overlapping Non-erosive Gastroesophageal Reflux Disease and Functional Dyspepsia Patients.

J Neurogastroenterol Motil. 2012-4-9

[3]
Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.

J Gastroenterol. 2019-1-23

[4]
Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.

J Gastroenterol Hepatol. 2018-3

[5]
Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.

Dis Esophagus. 2012-8-2

[6]
Causal effect of anxiety and depression status on the symptoms of gastroesophageal reflux disease and functional dyspepsia during proton pump inhibitor therapy.

Esophagus. 2023-4

[7]
Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial.

BMC Gastroenterol. 2013-10-1

[8]
Effects of acotiamide on functional dyspepsia patients with heartburn who failed proton pump inhibitor treatment in Japanese patients: A randomized, double-blind, placebo-controlled crossover study.

Neurogastroenterol Motil. 2020-2

[9]
Therapeutic strategy for the patients with coexisting gastroesophageal reflux disease and postprandial distress syndrome of functional dyspepsia.

JGH Open. 2020-2-3

[10]
Differences Between Patients with Heartburn Refractory to Vonoprazan and Those Refractory to Proton Pump Inhibitors.

Dig Dis Sci. 2024-6

引用本文的文献

[1]
Overlap Between Gastroesophageal Reflux Disease and Functional Dyspepsia: Do We Need a New Management Paradigm?

J Neurogastroenterol Motil. 2025-4-30

本文引用的文献

[1]
Characteristics and Risk Factors of Functional Dyspepsia Fulfilling the Rome IV Criteria Overlapping With Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Constipation in South China.

J Neurogastroenterol Motil. 2024-4-30

[2]
AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review.

Clin Gastroenterol Hepatol. 2023-6

[3]
Review article: Functional dyspepsia-a gastric disorder, a duodenal disorder or a combination of both?

Aliment Pharmacol Ther. 2023-4

[4]
Asia-Pacific guidelines for managing functional dyspepsia overlapping with other gastrointestinal symptoms.

J Gastroenterol Hepatol. 2023-2

[5]
Clinical practice guidelines for esophageal ambulatory reflux monitoring in Chinese adults.

J Gastroenterol Hepatol. 2022-5

[6]
Upright Integrated Relaxation Pressure Predicts Symptom Outcome for Esophagogastric Junction Outflow Obstruction.

J Neurogastroenterol Motil. 2021-7-30

[7]
Chinese expert consensus on gastroesophageal reflux disease in 2020.

J Dig Dis. 2021-7

[8]
Heartburn in children and adolescents in the presence of functional dyspepsia and/or irritable bowel syndrome correlates with the presence of sleep disturbances, anxiety, and depression.

Medicine (Baltimore). 2021-4-2

[9]
Effects of coexisting upper gastrointestinal symptoms on daily life and quality of life in patients with gastroesophageal reflux disease symptoms.

Esophagus. 2021-7

[10]
Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0.

Neurogastroenterol Motil. 2021-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索